VYVGART is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Argenx Us. The primary component is Efgartigimod Alfa.
Product ID | 73475-3041_03a14315-608c-4b82-a667-526841d98ea7 |
NDC | 73475-3041 |
Product Type | Human Prescription Drug |
Proprietary Name | VYVGART |
Generic Name | Efgartigimod Alfa |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2021-12-17 |
Marketing Category | BLA / |
Application Number | BLA761195 |
Labeler Name | argenx US |
Substance Name | EFGARTIGIMOD ALFA |
Active Ingredient Strength | 20 mg/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2021-12-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VYVGART 98008004 not registered Live/Pending |
Argenx B.V. 2023-05-22 |
VYVGART 90061747 not registered Live/Pending |
Argenx B.V. 2020-07-20 |